| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5588075 | Journal of Diabetes and its Complications | 2017 | 7 Pages |
Abstract
This meta-analysis of the 8 available controlled trials showed that DPP-4 inhibition in patients with type 2 diabetes mellitus was associated with significant reductions in plasma TNF-α levels with no apparent difference between sitagliptin and vildagliptin.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Stephen L. Atkin, Niki Katsiki, Maciej Banach, Dimitri P. Mikhailidis, Matteo Pirro, Amirhossein Sahebkar,